Job description
The Senior Research Scientist in the Mechanistic Biology team at Elanco will lead target identification and validation for animal diseases to enhance the drug discovery pipeline. This non-lab role focuses on guiding cross-functional teams through early-stage drug discovery using advanced techniques and AI/ML-driven platforms. The position emphasizes accelerating the discovery cycle through high-throughput screening approaches for both small molecules and biologics. The ideal candidate will contribute to innovative strategies that improve animal health and foster collaboration across various scientific disciplines.
Requirements
- Ph.D. in Cell/Molecular Biology, Pharmacology, Biochemistry, or a related field with several years of postdoctoral training.
- Professional experience in industry research and early-stage biotech/drug discovery, including CRO management.
- Expertise in target identification and validation, including biological assay development for small/large molecules.
- Expertise in New Approach Methodologies (NAMs) such as organoids/iPSCs and CRISPR/Cas9 screening.
Responsibilities
- Lead the identification and prioritization of novel targets using in vitro/in vivo experiments, literature reviews, bioinformatics, functional genomics, and AI/ML.
- Design and deploy high-throughput and multi-modal screening strategies to identify novel chemical and biological starting points.
- Guide cross-functional teams through early drug discovery from initial concept through target validation.
- Develop strategies to de-risk targets and enhance commercial viability by integrating Chemistry, Manufacturing, and Controls considerations.
- Manage external CRO partnerships and biotech collaborations, providing scientific expertise to support discovery campaigns.
Benefits
- Employees at Elanco are often offered competitive compensation with annual bonus and equity eligibility, retirement plans (including a U.S. 401(k)), and comprehensive health coverage—medical, dental, vision, company-paid life and disability—and even pet insurance. Time-off and flexibility typically include generous PTO, U.S. mid-year and year-end paid shutdown weeks, parental leave, and flexible/remote work options. Employees also benefit from strong development programs (onboarding, course libraries, mentorship, nine ERGs, and tiered leadership programs) that support both professional growth and community involvement.
H-1B filing history
Public USCIS petition and DOL LCA counts · latest USCIS FY2026, LCA FY2026
Combined across 2 filing entities: Elanco Us Inc, Elanco Animal Health Inc
As of Aug 23, 2026
Initial approvals
4
FY2026
Approval rate
100.0%
FY2026
LCA certified
12
FY2026
Entry-level share
0.0%
FY2026
Initial approvals YoY
+3%
Trend
LCA certified YoY
-25%
Trend
Initial approvals by fiscal year
Approval rate by fiscal year
Continuing vs initial approvals
LCA certified positions by quarter
LCA certified positions by fiscal year
Based on public USCIS and DOL filings; not a sponsorship guarantee.
Is this posting expired or inaccurate?
